体外受精与卵巢刺激下宫腔内人工授精治疗不明原因不孕:协作性个体参与者数据荟萃分析
本个体参与者数据荟萃分析纳入4项随机对照试验的934例不明原因不孕女性,比较体外受精(IVF)与卵巢刺激下宫腔内人工授精(IUI-OS)的累积活产率和多胎妊娠率。考虑妊娠时间后,IVF的累积活产率未显著高于IUI-OS(50.3% vs 43.2%,HR 1.19,95%CI 0.81-1.74),多胎妊娠率也无显著差异(3.8% vs 5.2%,OR 0.78,95%CI 0.41-1.50)。
要点
- 考虑妊娠时间后,IVF累积活产率未显著高于IUI-OS(50.3% vs 43.2%,HR 1.19,95%CI 0.81-1.74)。
- IVF多胎妊娠率未显著低于IUI-OS(3.8% vs 5.2%,OR 0.78,95%CI 0.41-1.50)。
- IVF与IUI-OS在有效性和安全性上均为可行选择,临床决策需权衡费用与夫妇偏好。
核心结论
- 无稳健证据表明不明原因不孕夫妇中IVF比IUI-OS更快实现导致活产的妊娠。
- IVF和IUI-OS在有效性和安全性上均为可行选择,临床决策需权衡干预费用和夫妇偏好。
研究设计与样本
- 个体参与者数据荟萃分析,检索MEDLINE、EMBASE、CENTRAL、PsycINFO、CINAHL和Cochrane妇产科与生育组专业注册库,纳入2021年6月前完成数据收集的随机对照试验,2023年1月更新检索。
- 8项可能合格的随机对照试验中2项待分类,其余6项中4项共享934例女性的个体参与者数据,其中550例分配至IVF,383例分配至IUI-OS。
- 采用偏倚风险2工具评估证据质量:2项随机对照试验高偏倚风险,1项有一些顾虑,1项低偏倚风险。
主要发现
- 考虑导致活产的妊娠时间,IVF累积活产率未显著高于IUI-OS(4项随机对照试验,908例女性,50.3% vs 43.2%,风险比1.19,95%CI 0.81-1.74,I²=42.4%)。
- IVF多胎妊娠率未显著低于IUI-OS(3项随机对照试验,890例女性,占所有随机夫妇的3.8% vs 5.2%,比值比0.78,95%CI 0.41-1.50,I²=0.0%)。
临床怎么用
- IVF和IUI-OS均为不明原因不孕的有效性和安全性可行选择,临床决策需权衡干预费用和夫妇偏好。
局限性
- 8项可能合格的随机对照试验中2项待分类,仅4项共享个体参与者数据。
- 因干预无法盲法,2项随机对照试验高偏倚风险,1项有一些顾虑。
- 累积活产率分析异质性I²=42.4%。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: IVF and IUI with ovarian stimulation (IUI-OS) are widely used in managing unexplained infertility. IUI-OS is generally considered first-line therapy, followed by IVF only if IUI-OS is unsuccessful after several attempts. However, there is a growing interest in using IVF for immediate treatment because it is believed to lead to higher live birth rates and shorter time to pregnancy. OBJECTIVE AND RATIONALE: Randomized controlled trials (RCTs) comparing IVF versus IUI-OS had varied study designs and findings. Some RCTs used complex algorithms to combine IVF and IUI-OS, while others had unequal follow-up time between arms or compared treatments on a per-cycle basis, which introduced biases. Comparing cumulative live birth rates of IVF and IUI-OS within a consistent time frame is necessary for a fair head-to-head comparison. Previous meta-analyses of RCTs did not consider the time it takes to achieve pregnancy, which is not possible using aggregate data. Individual participant data meta-analysis (IPD-MA) allows standardization of follow-up time in different trials and time-to-event analysis methods. We performed this IPD-MA to investigate if IVF increases cumulative live birth rate considering the time leading to pregnancy and reduces multiple pregnancy rate compared to IUI-OS in couples with unexplained infertility. SEARCH METHODS: We searched MEDLINE, EMBASE, CENTRAL, PsycINFO, CINAHL, and the Cochrane Gynaecology and Fertility Group Specialised Register to identify RCTs that completed data collection before June 2021. A search update was carried out in January 2023. RCTs that compared IVF/ICSI to IUI-OS in couples with unexplained infertility were eligible. We invited author groups of eligible studies to join the IPD-MA and share the deidentified IPD of their RCTs. IPD were checked and standardized before synthesis. The quality of evidence was assessed using the Risk of Bias 2 tool. OUTCOMES: Of eight potentially eligible RCTs, two were considered awaiting classification. In the other six trials, four shared IPD of 934 women, of which 550 were allocated to IVF and 383 to IUI-OS. Because the interventions were unable to blind, two RCTs had a high risk of bias, one had some concerns, and one had a low risk of bias. Considering the time to pregnancy leading to live birth, the cumulative live birth rate was not significantly higher in IVF compared to that in IUI-OS (4 RCTs, 908 women, 50.3% versus 43.2%, hazard ratio 1.19, 95% CI 0.81-1.74, I2 = 42.4%). For the safety primary outcome, the rate of multiple pregnancy was not significantly lower in IVF than IUI-OS (3 RCTs, 890 women, 3.8% versus 5.2% of all couples randomized, odds ratio 0.78, 95% CI 0.41-1.50, I2 = 0.0%). WIDER IMPLICATIONS: There is no robust evidence that in couples with unexplained infertility IVF achieves pregnancy leading to live birth faster than IUI-OS. IVF and IUI-OS are both viable options in terms of effectiveness and safety for managing unexplained infertility. The associated costs of interventions and the preference of couples need to be weighed in clinical decision-making.
引用
- Lai S, Wang R, van Wely M, et al. IVF versus IUI with ovarian stimulation for unexplained infertility: a collaborative individual participant data meta-analysis. Hum Reprod Update. 2024. PMID: 38148104. doi:10.1093/humupd/dmad033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。